The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prostate oncologic therapy while ensuring neurovascular conservation (POTEN-C): A phase II randomized controlled trial of stereotactic ablative body radiotherapy (SAbR) with or without neurovascular sparing for erectile function preservation in localized prostate cancer.
 
Neil Bipinchandra Desai
Research Funding - Boston Scientific
 
Michael Ryan Folkert
Research Funding - Boston Scientific
 
Andrew Leiker
No Relationships to Disclose
 
Yulong Yan
No Relationships to Disclose
 
Daniel N. Costa
No Relationships to Disclose
 
Robert Timothy Dess
No Relationships to Disclose
 
Daniel Eidelberg Spratt
Consulting or Advisory Role - Blue Earth Diagnostics; Janssen Oncology
 
Aurelie Garant
No Relationships to Disclose
 
Raquibul Hannan
Research Funding - Dendreon (Inst); Prometheus (Inst)
 
Robert D. Timmerman
Research Funding - Accuray (Inst); Elekta (Inst); Varian Medical Systems (Inst)